Simon Dumesnil - Oct 24, 2025 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role: Director
Signature: /s/ Simon Dumesnil
Stock symbol: KTTA
Transactions as of: Oct 24, 2025
Transactions value $: $0
Form type: 4
Date filed: 10/27/2025, 05:25 PM
Previous filing: Mar 1, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dumesnil Simon	Director	1111 LINCOLN ROAD,, SUITE 500, MIAMI BEACH	/s/ Simon Dumesnil	2025-10-27	0001875691

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KTTA	Stock Option (right to buy)	Award	$0	+42.9K		$0.00	42.9K	Oct 24, 2025	Common Stock	42.9K	$0.72	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Content

The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).